Search Results - "Locher, C"

Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists by Yamazaki, T, Hannani, D, Poirier-Colame, V, Ladoire, S, Locher, C, Sistigu, A, Prada, N, Adjemian, S, Catani, J PP, Freudenberg, M, Galanos, C, André, F, Kroemer, G, Zitvogel, L

“…Immunogenic cell death induced by anticancer chemotherapy is characterized by a series of molecular hallmarks that include the exodus of high-mobility group…”
Get full text

Artificial intelligence and the future of psychiatry: Qualitative findings from a global physician survey by Blease, C, Locher, C, Leon-Carlyle, M, Doraiswamy, M

“…Background The potential for machine learning to disrupt the medical profession is the subject of ongoing debate within biomedical informatics. Objective This…”
Get full text

Malnutrition Is High and Underestimated During Chemotherapy in Gastrointestinal Cancer: An AGEO Prospective Cross-Sectional Multicenter Study by Attar, A., Malka, D., Sabaté, J. M., Bonnetain, F., Lecomte, T., Aparicio, T., Locher, C., Laharie, D., Ezenfis, J., Taieb, J.

“…Although malnutrition is known to be frequent in cancer patients, it has not been described in a selected population of patients with gastrointestinal…”
Get full text

Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study by Zaanan, A., Costes, L., Gauthier, M., Malka, D., Locher, C., Mitry, E., Tougeron, D., Lecomte, T., Gornet, J.-M., Sobhani, I., Moulin, V., Afchain, P., Taïeb, J., Bonnetain, F., Aparicio, T.

“…Small-bowel adenocarcinoma (SBA) is a rare tumor of poor prognosis. Data on the efficacy of chemotherapy for advanced SBA are scarce. All patients with…”
Get full text

If only they knew! A non‐inferiority randomized controlled trial comparing deceptive and open‐label placebo in healthy individuals by Druart, L., Graham Longsworth, S. E., Terrisse, H., Locher, C., Blease, C., Rolland, C., Pinsault, N.

“…Background Placebo use is widespread in clinical practice. However, they are most often administered deceptively rather than openly. It is often suggested that…”
Get full text

Systematic review of animal models for the study of implant integration, assessing the influence of material, surface and design by Stadlinger, Bernd, Pourmand, Pedram, Locher, Michael C., Schulz, Matthias C.

“…Objectives The aim of this systematic review was to assess the scientific literature in terms of pre‐clinical studies evaluating the influence of material,…”
Get full text

Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study by Aparicio, T, Svrcek, M, Zaanan, A, Beohou, E, Laforest, A, Afchain, P, Mitry, Emmanuel, Taieb, J, Di Fiore, F, Gornet, J-M, Thirot-Bidault, A, Sobhani, I, Malka, D, Lecomte, T, Locher, C, Bonnetain, F, Laurent-Puig, P

“…Background: Small bowel adenocarcinoma (SBA) is a rare tumour with a poor prognosis. Molecular biology data on SBA carcinogenesis are lacking. Methods:…”
Get full text

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results by Aparicio, T., Bouché, O., Taieb, J., Maillard, E., Kirscher, S., Etienne, P.-L., Faroux, R., Khemissa Akouz, F., El Hajbi, F., Locher, C., Rinaldi, Y., Lecomte, T., Lavau-Denes, S., Baconnier, M., Oden-Gangloff, A., Genet, D., Paillaud, E., Retornaz, F., François, E., Bedenne, L.

“…Metastatic colorectal cancer frequently occurs in elderly patients. Bevacizumab in combination with front line chemotherapy (CT) is a standard treatment but…”
Get full text

Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study by Varnier, R., Toullec, C., Philonenko, S., Dupré, A., Artru, P., Hafliger, E., Drouillard, A., Torregrosa, C., Pernot, S., McLellan, P., Lecomte, T., Moulin, V., Lécaille, C., Touchefeu, Y., Locher, C., Taieb, J., Coutzac, C.

“…Prior trials validated triplet chemotherapy (Tri-CT) with bevacizumab as first line treatment for metastatic colorectal cancer (mCRC) but real-world data are…”
Get full text

Risk of anti-TNF therapy on pregnancy, breastfeeding, live vaccines and related information in patients with inflammatory bowel disease: Real-world data from a nationwide study by Bendaoud, S., Nahon, S., Beaugerie, L., Gornet, J.M., Wils, P., Amiot, A., Peyrin-Biroulet, L., Abitbol, V., Hébuterne, X., Altwegg, R., Rosa, I., Amil, M., Heluwaert, F., Plastaras, L., Stefanescu, C., Quentin, V., Antoni, M., Bideau, K., Boualit, M., Cuillerier, E., Locher, C., Skinazi, F., Boureille, A., Buisson, A., Simon, M.

“…Anti-TNF are usually maintained during pregnancy in patients with inflammatory bowel disease (IBD) but safety is still a concern for them. To provide data on…”
Get full text

The inferior alveolar nerve's loop at the mental foramen and its implications for surgery by Filo, Katharina, DMD, Schneider, Thomas, DMD, Locher, Michael C., MD, DMD, Kruse, Astrid L., MD, DMD, Lübbers, Heinz-Theo, MD, DMD

“…ABSTRACT Background In this study, the authors aimed to identify and measure the anterior extension of the alveolar loop (aAL) and the caudal extension of the…”
Get full text

Reasons for chemotherapy discontinuation and end of life in gastro-intestinal cancers: a multicentric prospective AGEO study by Palmieri, L., Dubreuil, O., Hautefeuille, V., Bachet, J., Trouilloud, I., Locher, C., Coriat, R., Moryoussef, F., Landi, B., Perkins, G., Doat, S.

Get full text

Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II–III colorectal cancer by Chaput, N, Svrcek, M, Aupérin, A, Locher, C, Drusch, F, Malka, D, Taïeb, J, Goéré, D, Ducreux, M, Boige, V

“…Background: The aim of our study was to evaluate the prognostic role of immunological microenvironnement in stage II–III CRC patients. Methods: We constructed…”
Get full text

Chemical characteristics and antimicrobial effects of some Eucalyptus kinos by von Martius, S., Hammer, K.A., Locher, C.

“…Eucalyptus kinos are tannin-rich, mostly red-coloured wood exudates. They have played an important role in the traditional medicines of Australian Aboriginal…”
Get full text

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results by Aparicio, T, Bouché, O, Taieb, J, Maillard, E, Kirscher, S, Etienne, P -L, Faroux, R, Khemissa Akouz, F, El Hajbi, F, Locher, C, Rinaldi, Y, Lecomte, T, Lavau-Denes, S, Baconnier, M, Oden-Gangloff, A, Genet, D, Paillaud, E, Retornaz, F, François, E, Bedenne, L

Get full text

Oral lichen planus (OLP), oral lichenoid lesions (OLL), oral dysplasia, and oral cancer: retrospective analysis of clinicopathological data from 2002–2011 by Casparis, S., Borm, J. M., Tektas, S., Kamarachev, J., Locher, M. C., Damerau, G., Grätz, K. W., Stadlinger, B.

“…Introduction This 10-year retrospective study analyzed the incidence of malignant transformation of oral lichen planus (OLP). The study also included dysplasia…”
Get full text

Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study by APARICIO, T, SVRCEK, M, THIROT-BIDAULT, A, SOBHANI, I, MALKA, D, LECOMTE, T, LOCHER, C, BONNETAIN, F, LAURENT-PUIG, P, ZAANAN, A, BEOHOU, E, LAFOREST, A, AFCHAIN, P, MITRY, Emmanuel, TAIEB, J, DI FIORE, F, GORNET, J.-M

Get full text

Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines by Hannani, D, Locher, C, Yamazaki, T, Colin-Minard, V, Vetizou, M, Aymeric, L, Viaud, S, Sanchez, D, Smyth, M J, Bruhns, P, Kroemer, G, Zitvogel, L

“…Immunogenic cell death induced by cytotoxic compounds contributes to the success of selected chemotherapies by eliciting a protective anticancer immune…”
Get full text

Operating experiences with a molten carbonate fuel cell at Stuttgart-Möhringen wastewater treatment plant by Locher, C, Meyer, C, Steinmetz, H

“…Fuel cells on wastewater treatment plants are a relatively new technology to convert biogas from anaerobic digestion into thermal and electrical energy. Since…”
Get full text

Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort by Colussi, O, Voron, T, Pozet, A, Hammel, P, Sauvanet, A, Bachet, J.B, Vaillant, J.C, Rougier, Ph, Nordlinger, B, Berger, A, Coriat, R, Dousset, B, Malka, D, André, T, Paye, F, Aparicio, T, Locher, C, Cojean Zeleck, D, Tchinou, L, Bonnetain, F, Taieb, J

“…Abstract Background Ampullary carcinoma (AC) is a relatively rare entity often managed as a biliopancreatic carcinoma. AC has a better prognosis than peri…”
Get full text